(Q39639721)

13 September 2017

title

Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells (English)

1 reference

13 September 2017

0 references

Yadong Feng

1

1 reference

13 September 2017

Hong Zhu

2

1 reference

13 September 2017

Tingsheng Ling

3

1 reference

13 September 2017

Bo Hao

4

1 reference

13 September 2017

Guoxin Zhang

5

1 reference

13 September 2017

Ruihua Shi

6

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20977428

10 August 2024

publication date

1 May 2011

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1042%2FCBI20090419

1 reference

Cell Biology International

10 August 2024

published in

1 reference

13 September 2017

volume

35

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

491-497

1 reference

Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

The magic of the hypoxia-signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Hypoxia-mediated tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

HIF gene expression in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Hypoxia-inducible factors: central regulators of the tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Is HIF-1alpha a pro- or an anti-apoptotic protein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

HIF-1 and tumor progression: pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Hypoxia-inducible factor 1 and cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

Tumor hypoxia and cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090419

The differential effects of mutant p53 alleles on advanced murine lung cancer

21 January 2018

15

1 reference

HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells

10 August 2024

25

1 reference

YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] Exhibits a Novel Antiproliferative Effect and Arrests the Cell Cycle in G0-G1 in Human Hepatocellular Carcinoma Cells

10 August 2024

34

1 reference

10 August 2024

Identifiers

DOI

10.1042/CBI20090419

1 reference

13 September 2017

1 reference